39042667|t|Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer's disease.
39042667|a|Reduction of amyloid beta (Abeta) has been shown to be effective in treating Alzheimer's disease (AD), but the underlying assumption that neurons are the main source of pathogenic Abeta is untested. Here, we challenge this prevailing belief by demonstrating that oligodendrocytes are an important source of Abeta in the human brain and play a key role in promoting abnormal neuronal hyperactivity in an AD knock-in mouse model. We show that selectively suppressing oligodendrocyte Abeta production improves AD brain pathology and restores neuronal function in the mouse model in vivo. Our findings suggest that targeting oligodendrocyte Abeta production could be a promising therapeutic strategy for treating AD.
39042667	49	61	amyloid beta	Gene	351
39042667	70	90	neuronal dysfunction	Disease	MESH:D009461
39042667	94	113	Alzheimer's disease	Disease	MESH:D000544
39042667	128	140	amyloid beta	Gene	351
39042667	142	147	Abeta	Gene	351
39042667	192	211	Alzheimer's disease	Disease	MESH:D000544
39042667	213	215	AD	Disease	MESH:D000544
39042667	295	300	Abeta	Gene	351
39042667	422	427	Abeta	Gene	351
39042667	435	440	human	Species	9606
39042667	489	511	neuronal hyperactivity	Disease	MESH:D001289
39042667	518	520	AD	Disease	MESH:D000544
39042667	530	535	mouse	Species	10090
39042667	596	601	Abeta	Gene	11820
39042667	622	624	AD	Disease	MESH:D000544
39042667	679	684	mouse	Species	10090
39042667	752	757	Abeta	Gene	351
39042667	824	826	AD	Disease	MESH:D000544
39042667	Association	MESH:D000544	11820
39042667	Association	MESH:D009461	351
39042667	Association	MESH:D001289	351
39042667	Association	MESH:D000544	351

